Medical aesthetics technology company providing minimally invasive surgical and non-surgical solutions.
InMode Ltd., headquartered in Yokneam, Israel, is a pioneering company at the forefront of minimally invasive aesthetic medical technologies. Specializing in proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies, InMode designs, develops, manufactures, and markets innovative products globally. These advanced technologies enable a wide range of minimally invasive aesthetic procedures, including simultaneous liposuction and skin tightening, body and facial contouring, and ablative skin rejuvenation treatments. Moreover, InMode's offerings extend to addressing women's health conditions and procedures, underscoring its commitment to comprehensive aesthetic solutions.
The company's portfolio includes non-invasive medical aesthetic products designed for various procedures such as permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, and improvement of skin appearance and texture. Additionally, InMode develops hands-free medical aesthetic products that target skin tightening, fat reduction, and muscle stimulation, enhancing convenience and effectiveness in aesthetic treatments.
Founded in 2008 as Invasix Ltd. and rebranded as InMode Ltd. in November 2017, the company has rapidly expanded its global footprint and reputation for innovation in aesthetic medical technology. Situated in Yokneam, Israel, a hub for biomedical research and development, InMode leverages its strategic location to drive continuous advancements in aesthetic medicine, collaborating closely with leading healthcare professionals and institutions worldwide.
With a steadfast commitment to advancing minimally invasive aesthetic solutions, InMode Ltd. continues to pioneer cutting-edge technologies that redefine the standards of cosmetic and aesthetic medical treatments. Through innovation, quality, and a dedication to meeting evolving patient needs, the company remains poised for continued growth and leadership in the dynamic field of aesthetic medicine.